Arcutis Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $81,504 | $65,846 | $71,360 | $44,755 |
Gross Profit | 74,012 | 57,016 | 64,455 | 39,252 |
EBITDA | -11,952 | -18,667 | -4,456 | -33,452 |
EBIT | -12,515 | -21,799 | -4,914 | -34,884 |
Net Income | -15,886 | -25,060 | -10,788 | -41,537 |
Net Change In Cash | 81,504 | 65,846 | 71,360 | 44,755 |
Free Cash Flow | 246 | -30,988 | -5,748 | -34,831 |
Cash | 73,048 | 53,104 | 71,335 | 134,851 |
Basic Shares | 126,997 | 126,037 | 120,958 | 124,302 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $196,542 | $59,606 | $3,686 | $0 |
Gross Profit | 177,414 | 54,619 | 2,932 | -763 |
EBITDA | -109,625 | -227,434 | -294,553 | -206,075 |
EBIT | -112,224 | -229,315 | -295,806 | -206,529 |
Net Income | -140,039 | -262,140 | -311,458 | -205,902 |
Net Change In Cash | 196,542 | 59,606 | 3,686 | 0 |
Cost of Revenue | 31,367 | |||
Free Cash Flow | -112,301 | -247,485 | -280,998 | -175,622 |
Cash | 71,335 | 88,398 | 53,641 | 96,449 |
Basic Shares | 120,958 | 69,305 | 55,032 | 49,406 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.13 |
2025-03-31 | -$0.20 |
2024-12-31 | -$0.09 |
